Detalles de la búsqueda
1.
Illustrating the financial consequences of outcome-based payment models from a payers perspective- the case of autologous gene therapy atidarsagene autotemcel (Libmeldy®).
Value Health
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795960
2.
The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries' past health technology assessments.
Int J Technol Assess Health Care
; 39(1): e44, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317832
3.
Reported Challenges in Health Technology Assessment of Complex Health Technologies.
Value Health
; 25(6): 992-1001, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35667787
4.
Understanding innovation of health technology assessment methods: the IHTAM framework.
Int J Technol Assess Health Care
; 38(1): e16, 2022 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094736
5.
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
Int J Technol Assess Health Care
; 38(1): e17, 2022 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094740
6.
Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America.
Rev Panam Salud Publica
; 46: e115, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36060200
7.
Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios.
Value Health
; 24(6): 759-769, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34119073
8.
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients.
Value Health
; 24(1): 121-128, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431146
9.
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.
Int J Technol Assess Health Care
; 37(1): e83, 2021 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34424152
10.
Efficacy gap between phase II and subsequent phase III studies in oncology.
Br J Clin Pharmacol
; 86(7): 1306-1313, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32034790
11.
Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
Value Health
; 23(1): 10-16, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31952664
12.
Increasing the information provided by probabilistic sensitivity analysis: The relative density plot.
Cost Eff Resour Alloc
; 18(1): 54, 2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292291
13.
Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions.
Value Health
; 22(11): 1275-1282, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708064
14.
Lifecycle HTA: Promising applications and a framework for implementation.
Int J Technol Assess Health Care
; : 1-25, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727087
15.
An operationalization framework for lifecycle HTA.
Int J Technol Assess Health Care
; : 1-29, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751240
16.
Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations.
Clin Pharmacol Ther
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38505926
17.
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries.
Expert Rev Pharmacoecon Outcomes Res
; 24(2): 181-187, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37970637
18.
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis.
BMJ Open
; 14(2): e075173, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355183
19.
A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes.
Diabetes Res Clin Pract
; 209: 111574, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346592
20.
Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook.
Drug Discov Today
; 28(1): 103433, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372328